Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Mar 26, 2019 9:29am

71 Views

Post# 29535794

RE:RE:RE:RE:RE:News is out---

Commencing in Q2 does not necessarily mean treating patients in Q2. They would likely consider enrolling patients as the official start of the trial. Has everyone already forgotten the slow progress of the phase 1b trial after they announced its start? You're also forgetting 1 key ingredient and that's FDA involvement. Without it I can't see how you can attract the attention you will need if you expect the sp some posters are quoting.

Bullboard Posts

Drilling underway at a large copper-moly porphyry target in Peru